Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial.

Schwameis M, Kündig T, Huber G, von Bidder L, Meinel L, Weisser R, Aberer E, Härter G, Weinke T, Jelinek T, Fätkenheuer G, Wollina U, Burchard GD, Aschoff R, Nischik R, Sattler G, Popp G, Lotte W, Wiechert D, Eder G, Maus O, Staubach-Renz P, Gräfe A, Geigenberger V, Naudts I, Sebastian M, Reider N, Weber R, Heckmann M, Reisinger EC, Klein G, Wantzen J, Jilma B

Open source

DOI
10.1016/s1473-3099(16)30529-1
Published
2017 Mar
Container
The Lancet. Infectious diseases
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-16-30529-1,
  title = {Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial.},
  author = {Schwameis M and Kündig T and Huber G and von Bidder L and Meinel L and Weisser R and Aberer E and Härter G and Weinke T and Jelinek T and Fätkenheuer G and Wollina U and Burchard GD and Aschoff R and Nischik R and Sattler G and Popp G and Lotte W and Wiechert D and Eder G and Maus O and Staubach-Renz P and Gräfe A and Geigenberger V and Naudts I and Sebastian M and Reider N and Weber R and Heckmann M and Reisinger EC and Klein G and Wantzen J and Jilma B},
  year = {2017},
  journal = {The Lancet. Infectious diseases},
  doi = {10.1016/s1473-3099(16)30529-1},
  url = {https://doi.org/10.1016/s1473-3099(16)30529-1}
}

RIS

TY  - JOUR
TI  - Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial.
AU  - Schwameis M
AU  - Kündig T
AU  - Huber G
AU  - von Bidder L
AU  - Meinel L
AU  - Weisser R
AU  - Aberer E
AU  - Härter G
AU  - Weinke T
AU  - Jelinek T
AU  - Fätkenheuer G
AU  - Wollina U
AU  - Burchard GD
AU  - Aschoff R
AU  - Nischik R
AU  - Sattler G
AU  - Popp G
AU  - Lotte W
AU  - Wiechert D
AU  - Eder G
AU  - Maus O
AU  - Staubach-Renz P
AU  - Gräfe A
AU  - Geigenberger V
AU  - Naudts I
AU  - Sebastian M
AU  - Reider N
AU  - Weber R
AU  - Heckmann M
AU  - Reisinger EC
AU  - Klein G
AU  - Wantzen J
AU  - Jilma B
PY  - 2017
JO  - The Lancet. Infectious diseases
DO  - 10.1016/s1473-3099(16)30529-1
UR  - https://doi.org/10.1016/s1473-3099(16)30529-1
ER  - 

APA

M, S., T, K., G, H., L, V. B., L, M., R, W., E, A., G, H., T, W., T, J., G, F., U, W., GD, B., R, A., R, N., G, S., G, P., W, L., D, W., G, E., O, M., P, S., A, G., V, G., I, N., M, S., N, R., R, W., M, H., EC, R., G, K., J, W., & B, J. (2017). Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial.. The Lancet. Infectious diseases. https://doi.org/10.1016/s1473-3099(16)30529-1

Source records